Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Activist Jeff Smith’s Five Favorite Stock Picks

Page 1 of 2

For almost a decade and a half, Jeffrey Smith‘s billion dollar activist hedge fund, Starboard Value, has struck fear in the management suite of his targets. Smith is willing to do whatever it takes, including fighting with entrenched management in proxy fights, to unlock value for shareholders. Seeing as Starboard Value’s annual return has averaged around 16% since 2002, Smith has done an admirable job unlocking value for his fund holders and for the shareholders of his target companies. Given that Starboard Value recently filed its 13F for the first quarter, let’s take a closer look at the fund’s top picks of Yahoo! Inc. (NASDAQ:YHOO), Darden Restaurants, Inc. (NYSE:DRI), Advance Auto Parts, Inc. (NYSE:AAP), Marvell Technology Group Ltd. (NASDAQ:MRVL), and WestRock Co (NYSE:WRK).

We believe that imitating hedge funds and other large institutional investors can be helpful in identifying stocks capable of outperforming the broader market. Through extensive research that covered portfolios of several hundred large investors between 1999 and 2012, we determined that following the small-cap stocks that large money managers are collectively bullish on, can generate monthly returns nearly 1.0 percentage points above the market (see the details here).

Jeffrey Smith
Jeffrey Smith
Starboard Value LP

#5 WestRock Co (NYSE:WRK)

Shares held (as of March 31): 4.57 million

Total Value (as of March 31): $178.22 million

Percent of Portfolio (as of March 31): 6.27%

Starboard raised its stake in WestRock Co (NYSE:WRK) by 2% to 4.57 million shares during the first quarter. That translates to a stake of $178.2 million, worth 6.26% of Starboard’s equity portfolio. WestRock reported strong fiscal second quarter earnings of $0.61 per share on revenue of $3.7 billion in April. The company delivered solid operating results in its consumer and corrugated packaging segment and realized $350 million in run-rate synergies from the combination between Rock-Tenn Company and MeadWestvaco Corporation in 2015. Although shares of WestRock have rallied since February, the stock is arguably still cheap with a forward P/E of 13.6.

Follow Westrock Co (NYSE:WRK)
Trade (NYSE:WRK) Now!

#4 Marvell Technology Group Ltd. (NASDAQ:MRVL)

Shares held (as of March 31): 20.4 million

Total Value (as of March 31): $210.3 million

Percent of Portfolio (as of March 31): 7.39%

Marvell Technology Group Ltd. (NASDAQ:MRVL) was a new position for Starboard in the first quarter. Smith’s fund bought 20.4 million shares, worth $210.3 million, which accounted for 7.39% of the equity portfolio at the end of March. On the account of increased industry oversupply, the company has faced some top-line pressures and had to restructure its mobile chip division to improve earnings. Because of the poor performance, the company’s founder and CEO, Sehat Sutardja resigned in early April, and later that month, Marvell entered into an agreement with Starboard Value LP, under the terms of which the hedge fund got to add four representatives to the company’s board of directors. Starboard will most likely push for major cost cuts or strategic initiatives to unlock shareholder value. Cliff Asness’ AQR Capital Management is another major shareholder of Marvell Technology.

Follow Marvell Technology Group Ltd (NASDAQ:MRVL)
Trade (NASDAQ:MRVL) Now!

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!